Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

Radiolabeling of DOTATOC with 44T/44Sc generator-derived 44Sc

Marek Pruszynski, Natalia Loktionova, Agnieszka Majkowska and Frank Roesch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1534;
Marek Pruszynski
2Institute of Nuclear Chemistry and Technology, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Loktionova
1Johannes Gutenberg Univ., Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnieszka Majkowska
2Institute of Nuclear Chemistry and Technology, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Roesch
1Johannes Gutenberg Univ., Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1534

Objectives The radionuclide 44Sc with 3.97 h half-life and 94.3% positron branching is of potential interest for clinical PET. It is available from a 44Ti/44Sc generator. 44Sc(III) may be used to synthesize radiopharmaceuticals analogously to currently used radionuclides such as 68Ga, 111In, 90Y or 177Lu. A key question was whether the coordination chemistry of Sc(III) is equivalent to established tetraaza- or triaza-based macrocyclic ligands. The aim of this work was to investigate, as a proof-of-principle, 44Sc-labeling of DOTA-conjugated peptides.

Methods 21 nmol of DOTATOC in 2 mL of a processed 44Sc eluate in ammonium acetate buffer pH = 4.0 were used. Reaction buffer conditions, pH range, temperature and time were optimized. Stability of 44Sc-DOTATOC was analyzed in challenge assays using excess of other metals (Fe3+, Ca2+, Cu2+, Mg2+) or other ligands like EDTA and DTPA.

Results Labeling was >98% within 25 minutes of heating in an oil-bath at 95°C or within 3 min only by applying microwave-supported heating. Isolation of the pure 44Sc-labeled product is performed on C-18 mini-cartridges (Strata-X) and results in radiochemically pure 44Sc-DOTATOC in 400 µL of pure ethanol. 44Sc-DOTATOC at 130 MBq activity is stable in ethanolic solution, 0.9% NaCl, phosphate buffer with sodium chloride (PBS pH = 7.4), and also in the presence of metal cations as well as other ligands.

Conclusions Incorporation of 44Sc(III) into DOTATOC is almost quantitative at pH 4.0. This radiochemically pure and chemically stable 44Sc-DOTATOC may allow follow-up research on PET/CT imaging making advantage of the 3.97 h half-life of this positron emitter. A specific field may be the application of 44Sc tracers matching therapeutic applications of analogue compounds labeled with e.g. 90Y or 177Lu, but also with the β- emitter 47Sc

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiolabeling of DOTATOC with 44T/44Sc generator-derived 44Sc
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiolabeling of DOTATOC with 44T/44Sc generator-derived 44Sc
Marek Pruszynski, Natalia Loktionova, Agnieszka Majkowska, Frank Roesch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1534;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiolabeling of DOTATOC with 44T/44Sc generator-derived 44Sc
Marek Pruszynski, Natalia Loktionova, Agnieszka Majkowska, Frank Roesch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1534;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

  • In vivo evaluation of EGCG stabilized gold-198 nanoparticles in prostate cancer bearing mice
  • New Tc-carbonyl based octreotide derivatives
  • uPAR Targeted SPECT imaging probes for detection of breast cancer
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

New Radiopharmaceuticals-Oncology Posters

  • F-18 labeled ethanolamine derivatives for tumor imaging - Comparison with F-18 ethylcholine
  • Radiosynthesis and evaluation of 68Ga-Cys2-AnxA5 and 68Ga-Cys165-AnxA5 as apoptosis imaging agents
  • Evaluation of 68Ga/68Ge generator and preparation of a 68Ga-DOTA-hapten-peptide for bispecific antibody (bsMAb) pretargeting
Show more New Radiopharmaceuticals-Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire